the Distance From Decompensated Heart Failure To the Editor: We read with great interest the recent article by Tang et al1 on plasma brain natriuretic peptide (BNP) levels in ambulatory patients with established chronic symptomatic systolic heart failure. They concluded that both symptomatic and asymptomatic patients present with a wide range of plasma BNP levels and that this heterogeneity may...

1024x768 normal 0 false false false en-us x-none fa background : heart failure is a common health problem with poor prognosis. the gold standard for diagnosis is echocardiography but it is not always reachable, especially in emergency conditions. nt-pro-brain natriuretic peptide (nt-probnp) is a novel indicator for the diagnosis of heart failure and is being used in routine tests in emergency r...

In the present study, we assessed the use of urinary natriuretic peptides [N-terminal proatrial natriuretic peptide (N-ANP) and N-terminal pro-brain natriuretic peptide (N-BNP) and C-type natriuretic peptide (CNP)] in the diagnosis of heart failure. Thirty-four consecutive hospitalized heart failure patients (median age, 75.5 years; 14 female) were compared with 82 age- and gender-matched echoc...

Background Although the left ventricle is the major site of BNP secretion in response to cardiac pressure or volume overload, the myocytes of both atria and ventricles secrete B- type natriuretic peptide (BNP). This study aimed to assess and compare the plasma levels of BNP in common pediatric cardiac diseases to clarify its pathophysiological role and evaluate its po...

normal 0 false false false en-us x-none ar-sa dear editor with interest, i read the article by khalilian et al. 1 recently published in your journal. we know that in adult patients, atrial natriuretic peptides (anp) and brainnatriuretic peptides (bnp) have been used for diagnosis, monitoring of treatment effects, and estimating the prognosis of systolic and diastolic heart failure. 2 furthermor...

ObjectiveThis study aimed to assess Brain Natriuretic Peptide in early diagnose of cardiac function in children with Congenital Heart Diseases.MethodologyThis study was performed on children with CHD and healthy. Severity of heart failure modified Ross classification system was used for grouping patients in four classes. For all participants, height, weight and head circumference were measured....

New York Heart Association (NYHA) classification is popularly used to evaluate severity of stable chronic heart failure. Since this evaluation depends on subjective symptoms such as dyspnoea or fatigue with exertion, it is not expected to provide a precise reflection of physiologic abnormality. Useful objective indices to evaluate severity of heart failure are peak oxygen uptake (V~O2) and minu...

objectivethis study aimed to assess brain natriuretic peptide in early diagnose of cardiac function in children with congenital heart diseases.methodologythis study was performed on children with chd and healthy. severity of heart failure modified ross classification system was used for grouping patients in four classes. for all participants, height, weight and head circumference were measured....

OBJECTIVE To determine plasma levels of N-terminal pro-brain natriuretic peptide (N-BNP) in control children to establish a normal age-dependent range from the neonatal period to adulthood. In addition, plasma concentrations of N-BNP were measured in children with congestive heart failure (CHF) and correlated with ejection fraction and clinical symptoms of heart failure. METHODS For establish...

Plasma concentrations of the recently discovered hormones adrenomedullin (ADM), from vascular tissue, and brain natriuretic peptide (BNP), secreted by myocardium, are elevated in patients with heart failure. We tested the hypotheses that short-term increments in circulating levels of these hormones, within the pathophysiological range, would have biological effects and that the 2 hormone system...